Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MB04 vs Enbrel in Moderate to Severe Rheumatoid Arthritis
NCT06596772Phase 3Completed
- Sponsor
- mAbxience
- Start
- Oct 2024
- Primary completion
- Feb 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 6
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by mAbxience. Started Oct 2024; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06596772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06596772.